As of 2026-02-03, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (8.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 103.80 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -108.2%.
The range of the Relative Valuation is (6.16) - (11.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 14.3x | 9.7x |
| Forward P/E multiples | 7.6x - 15.1x | 11.4x |
| Fair Price | (6.16) - (11.55) | (8.53) |
| Upside | -105.9% - -111.1% | -108.2% |
| Date | P/E |
| 2026-01-30 | -127.41 |
| 2026-01-29 | -127.04 |
| 2026-01-28 | -124.48 |
| 2026-01-27 | -122.53 |
| 2026-01-26 | -119.63 |
| 2026-01-23 | -116.39 |
| 2026-01-22 | -118.54 |
| 2026-01-21 | -115.13 |
| 2026-01-20 | -113.43 |
| 2026-01-16 | -112.39 |
| 2026-01-15 | -113.96 |
| 2026-01-14 | -111.89 |
| 2026-01-13 | -111.64 |
| 2026-01-12 | -110.47 |
| 2026-01-09 | -106.86 |
| 2026-01-08 | -100.72 |
| 2026-01-07 | -101.19 |
| 2026-01-06 | -94.38 |
| 2026-01-05 | -93.27 |
| 2026-01-02 | -96.37 |
| 2025-12-31 | -97.50 |
| 2025-12-30 | -97.33 |
| 2025-12-29 | -99.01 |
| 2025-12-26 | -97.84 |
| 2025-12-24 | -99.67 |
| 2025-12-23 | -98.81 |
| 2025-12-22 | -100.07 |
| 2025-12-19 | -95.96 |
| 2025-12-18 | -86.75 |
| 2025-12-17 | -85.17 |
| 2025-12-16 | -82.76 |
| 2025-12-15 | -79.12 |
| 2025-12-12 | -80.23 |
| 2025-12-11 | -81.12 |
| 2025-12-10 | -79.83 |
| 2025-12-09 | -80.73 |
| 2025-12-08 | -83.81 |
| 2025-12-05 | -84.53 |
| 2025-12-04 | -88.29 |
| 2025-12-03 | -87.63 |
| 2025-12-02 | -86.26 |
| 2025-12-01 | -86.42 |
| 2025-11-28 | -90.17 |
| 2025-11-26 | -90.27 |
| 2025-11-25 | -88.58 |
| 2025-11-24 | -89.12 |
| 2025-11-21 | -87.60 |
| 2025-11-20 | -85.37 |
| 2025-11-19 | -86.94 |
| 2025-11-18 | -89.11 |